Search results for: 'analytics market'

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...

30 Mar 2023  |  North America  |  Customer Research

Global Laboratory Product Purchasing Trends, 2022–2023

End–user Perspectives on Laboratory Spending Reveals Modest 2023 Budget Increases Following robust 2022 Spending

Infographics

×

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey from October to November 2022 examining their laboratories’ product purchasing process in 2022 and expectations for 2023. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The study presents year-over-...

Comprehensive wound assessment is vital to understand the nature of wounds and devise evidence-based and cost-effective therapeutic interventions. However, traditionally used methods for wound diagnosis and monitoring cannot accurately measure wound dimensions, require physical contact with the wound, which causes discomfort to the patients, and ca...

The adoption of hemodynamic monitoring systems is growing in hospitals, driven by the development of advanced sensors for minimally invasive and noninvasive monitoring. Advancements in wearable and remote monitoring technologies are forecast to support adoption in out-of-hospital settings in the next decade. Vendors are increasingly investing in de...

Hospitals are under extreme pressure to reduce or cut costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical hospital issues entail finding new methods to reduce human errors and improve efficiency and quality of surgical care. New technology is now available to help hos...

10 May 2018  |  North America  |  Market Research

Global Tissue Diagnostics Market, Forecast to 2022

Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market

Infographics

×

Key Issues Addressed

Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pat...

09 Mar 2023  |  Global  |  Market Research

Global Surgical Navigation Systems Market, Forecast to 2027

Competitive Intensity Driven by Digitally Led Business Models Creates New Growth Opportunities

Infographics

×

This study provides an overview of the global surgical navigation system market and covers technological solutions, including electromagnetic navigation systems, optical navigation systems, and hybrid navigation systems. The geographical scope is North America, Europe, and Asia-Pacific. It offers a detailed analysis of market sizing, trends, compet...

12 May 2025  |  Global  |  Market Research

Clinical Decision Support System Market, Global, 2024–2030

AI Integration is Driving Transformational Growth by Enabling Improvements in Clinical Outcomes

Infographics

×

The increasing focus on effective population health management is prompting healthcare organizations to adopt next-generation clinical decision support tools that drive market growth. Healthcare systems continue to face significant clinical quality and efficiency challenges, leading to a heightened focus on implementing clinical decision support sy...

23 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: US Liquid Biopsy, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...